Effects of CCR2 and CCR5 polymorphisms on HIV-1 infection in Thai females

被引：12
|
作者：
Wichukchinda, Nuanjun [2 ]
Nakayama, Emi E. [1 ]
Rojanawiwat, Archawin [2 ]
Pathipvanich, Panita [3 ]
Auwanit, Rattana [2 ]
Vongsheree, Suthon [2 ]
Ariyoshi, Koya [4 ]
Sawanpanyalert, Pathom [2 ]
Shioda, Tatsuo [1 ]
机构：
[1] Osaka Univ, Res Inst Microbial Dis, Dept Viral Infect, Suita, Osaka 5650871, Japan
[2] Natl Inst Hlth, Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand
[3] Lampang Hosp, Day Care Ctr, Lampang, Thailand
[4] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2008年 / 47卷 / 03期
关键词：
CCR2; CCR5; SNPs; HIV-1; infection; Thai;
D O I：
10.1097/QAI.0b013e318162caab
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Polymorphisms in CCR2 and CCR5 genes reportedly affect HIV-1 transmission and disease progression in HIV-1-infected individuals. In the study presented here, we examined the effects of CCR2 and CCR5 polymorphisms on HIV-1 transmission in 74 Thai females who were exposed to HIV but seronegative (ESN) and in 347 HIV-seropositive females. We found that the combination of 2 non-synonymous substitutions, CCR2 V641 and CCR5 G316A, tended to occur more frequently in ESN females (2 of 74) than in HIV-1-infected females (I of 347) (P = 0.08). This suggested that non-synonymous substitution in the CCR5 gene also affects HIV-1 transmission in an Asian population in which the CCR5-Delta 32 is very rare.
引用
收藏
页码：293 / 297
页数：5
相关论文
共 50 条
  • [31] CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
    He, JL
    Chen, YZ
    Farzan, M
    Choe, HY
    Ohagen, A
    Gartner, S
    Busciglio, J
    Yang, XY
    Hofmann, W
    Newman, W
    Mackay, CR
    Sodroski, J
    Gabuzda, D
    [J]. NATURE, 1997, 385 (6617) : 645 - 649
  • [32] Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4
    Shieh, B
    Liau, YE
    Hsieh, PS
    Yan, YP
    Wang, ST
    Li, C
    [J]. INTERNATIONAL IMMUNOLOGY, 2000, 12 (09) : 1311 - 1318
  • [33] Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran
    Heydarifard, Zahra
    Tabarraei, Alijan
    Moradi, Abdolvahab
    [J]. DISEASE MARKERS, 2017, 2017
  • [34] CCR5 HIV-1 vertical transmission
    Shearer, WT
    Kalish, LA
    Zimmerman, PA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (02): : 180 - 181
  • [35] CCR5 inhibitors in HIV-1 therapy
    Dorr, Patrick
    Perros, Manos
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (11) : 1345 - 1361
  • [36] Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
    Ogilvie, P
    Bardi, G
    Clark-Lewis, I
    Baggiolini, M
    Uguccioni, M
    [J]. BLOOD, 2001, 97 (07) : 1920 - 1924
  • [37] Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc
    Latinovic, Olga
    Kuruppu, Janaki
    Davis, Charles
    Le, Nhut
    Heredia, Alonso
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1497 - 1510
  • [38] HIV-1 infection in an individual homozygous for the CCR5 deletion allele
    Robyn Biti
    Rosemary Ffrench
    Judy Young
    Bruce Bennetts
    Graeme Stewart
    Tong Liang
    [J]. Nature Medicine, 1997, 3 : 252 - 253
  • [39] HIV-1 infection in an individual homozygous for the CCR5 deletion allele
    Biti, R
    French, RF
    Young, J
    Bennetts, B
    Stewart, G
    Liang, T
    [J]. NATURE MEDICINE, 1997, 3 (03) : 252 - 253
  • [40] HIV-1 infection in an individual homozygous for CCR5 Delta 32
    Theodorou, I
    Meyer, L
    Magierowska, M
    Katlama, C
    Rouzioux, C
    [J]. LANCET, 1997, 349 (9060): : 1219 - 1220
12345